$57.93
ANI Pharmaceuticals is a drug manufacturers - specialty & generic business based in the US. ANI Pharmaceuticals shares (ANIP) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $58.50 – an increase of 3.01% over the previous week. ANI Pharmaceuticals employs 642 staff and has a trailing 12-month revenue of around $539 million.
What's in this guide?
- ANIP shares summary
- Compare share dealing platforms
- Is ANIP stock a buy or sell?
- Stock performance over time
- Can I short ANIP shares?
- Are ANIP shares over-valued?
- ANI Pharmaceuticals's financials
- How volatile are ANIP shares?
- Does ANI Pharmaceuticals pay a dividend?
- Have ANIP shares ever split?
- Other common questions
Our top picks for where to buy ANI Pharmaceuticals stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
How to buy ANI Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ANIP. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy ANI Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
ANI Pharmaceuticals stock price (NASDAQ: ANIP)
Use our graph to track the performance of ANIP stocks over time.ANI Pharmaceuticals shares at a glance
Latest market close | $58.50 |
---|---|
52-week range | $48.20 - $70.81 |
50-day moving average | $60.01 |
200-day moving average | $61.72 |
Wall St. target price | $82.40 |
PE ratio | 47.7227 |
Dividend yield | N/A |
Earnings per share (TTM) | $1.19 |
Is it a good time to buy ANI Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ANI Pharmaceuticals price performance over time
Historical closes compared with the close of $58.5 from 2024-10-14
1 week (2024-10-08) | 3.01% |
---|---|
1 month (2024-09-13) | -0.02% |
3 months (2024-07-15) | -7.47% |
6 months (2024-04-15) | -11.76% |
1 year (2023-10-13) | 1.46% |
---|---|
2 years (2022-10-14) | 76.10% |
3 years (2021-10-13) | 53.30% |
5 years (2019-10-15) | 71.89 |
Is ANI Pharmaceuticals stock undervalued or overvalued?
Valuing ANI Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ANI Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ANI Pharmaceuticals's P/E ratio
ANI Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 48x. In other words, ANI Pharmaceuticals shares trade at around 48x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
ANI Pharmaceuticals's PEG ratio
ANI Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.06. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ANI Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
ANI Pharmaceuticals's EBITDA
ANI Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $108 million.
The EBITDA is a measure of a ANI Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.
ANI Pharmaceuticals financials
Revenue TTM | $539 million |
---|---|
Operating margin TTM | 6.54% |
Gross profit TTM | $177.6 million |
Return on assets TTM | 3.38% |
Return on equity TTM | 5.9% |
Profit margin | 5.01% |
Book value | $23.31 |
Market Capitalization | $1.2 billion |
TTM: trailing 12 months
ANI Pharmaceuticals share dividends
We're not expecting ANI Pharmaceuticals to pay a dividend over the next 12 months.
Have ANI Pharmaceuticals's shares ever split?
ANI Pharmaceuticals's shares were split on a 1:6 basis on 17 July 2013. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ANI Pharmaceuticals shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for ANI Pharmaceuticals shares which in turn could have impacted ANI Pharmaceuticals's share price.
ANI Pharmaceuticals share price volatility
Over the last 12 months, ANI Pharmaceuticals's shares have ranged in value from as little as $48.2 up to $70.81. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ANI Pharmaceuticals's is 0.71. This would suggest that ANI Pharmaceuticals's shares are less volatile than average (for this exchange).
ANI Pharmaceuticals overview
ANI Pharmaceuticals, Inc. , a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota. .
Frequently asked questions
nullWhat percentage of ANI Pharmaceuticals is owned by insiders or institutions?
Currently 11.149% of ANI Pharmaceuticals shares are held by insiders and 83.64% by institutions. How many people work for ANI Pharmaceuticals?
Latest data suggests 642 work at ANI Pharmaceuticals. When does the fiscal year end for ANI Pharmaceuticals?
ANI Pharmaceuticals's fiscal year ends in December. Where is ANI Pharmaceuticals based?
ANI Pharmaceuticals's address is: 210 Main Street West, Baudette, MN, United States, 56623 What is ANI Pharmaceuticals's ISIN number?
ANI Pharmaceuticals's international securities identification number is: US00182C1036 What is ANI Pharmaceuticals's CUSIP number?
ANI Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 09065V302
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
9 Best Discount Brokers of 2024 for Low-Cost Trading
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question